Startup profile · funding coverage
Q Bio
Quantitative preventive-health platform with full-body MRI and longitudinal biomarkers.
Stage
growth
Status
private
Coverage
full
Why Q Bio is interesting
Stanford's Mike Snyder co-founded; a16z + Khosla backing Tensor Field Mapping scan tech.
Key facts
- a16z portfolio status: Active
- Series B (2020): $40M led by a16z; Khosla and Founders Fund on board (Business Wire)
- Strategic (2024): $27M for Mark I full-body MRI scanner manufacturing (STAT)
Investors in our directory
Funds linked from Q Bio's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Biotech & Life Sciences
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover Q Bio's financing or category context.
Last updated: 2026-07-24